Neurogene falls ~47% in after-hours trading after a patient experienced a severe adverse event in a trial for its Rett syndrome gene therapy.
https://seekingalpha.com/news/4276690-neurogene-plummets-35-gene-therapy-trial-data-rett-syndrome
Neurogene falls ~47% in after-hours trading after a patient experienced a severe adverse event in a trial for its Rett syndrome gene therapy.
https://seekingalpha.com/news/4276690-neurogene-plummets-35-gene-therapy-trial-data-rett-syndrome
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.